5 most recent filings and news items mentioning CRBP. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/CRBP/news?limit=20"
Pull CRBP filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayCorbus Pharmaceuticals secured FDA clearance for the Phase 3 TEMPO-1 study of CRB-701 in oropharyngeal cancer and announced leadership appointments to advance its clinical pipeline toward 2026 milestones.
View filing at SEC.gov →Crescent Biopharma Inc. entered an underwriting agreement with Jefferies LLC and TD Securities to sell 8,094,793 shares and relevant warrants. This capital raise allows the Cayman Islands company to proceed with its planned public offering.
View filing at SEC.gov →Corbus Pharmaceuticals Holdings, Inc. entered into an employment agreement with Leonardo Viana Nicacio, M.D. to serve as Chief Medical Officer effective August 3, 2026. The appointment of key personnel is a routine corporate governance matter.
View filing at SEC.gov →Corbus Pharmaceuticals announced updated Phase 1/2 data showing CRB-701 demonstrated robust activity in second-line oropharyngeal and cervical cancers with confirmed response rates of 42.9% and 34.4% respectively, with a favorable safety profile. The company plans to initiate a r
View filing at SEC.gov →Corbus Pharmaceuticals has entered into an employment agreement with Nishant Saxena to serve as Chief Business Officer, effective May 21, 2026, with an annual base salary of $470,000. The appointment reflects the company's leadership expansion in its business development and stra
View filing at SEC.gov →